Onconephrology 2022: An Update.


Journal

Kidney360
ISSN: 2641-7650
Titre abrégé: Kidney360
Pays: United States
ID NLM: 101766381

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 19 09 2022
accepted: 15 12 2022
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Onconephrology is an upcoming and expanding subspecialty that deals with the intersections between hematology/oncology and nephrology. With the paradigm shift in the understanding of cancer immunobiology and mechanisms of oncotherapeutic drug toxicities, it is important for a nephrologist to have a sound understanding of this field. Over the last 5 years, there have been immense developments in our understanding of kidney-related adverse events from various targeted, immuno- and cellular-based therapies. Pathogenic mechanisms of electrolyte imbalance, hypertension (oncohypertension), and AKI from multiple forms of cancer therapies have been explored. Significant research has also been conducted in the field of transplant onconephrology. In this review, we have tried to assimilate the most recent updates in the last 2 years in this ever-growing and fascinating field.

Identifiants

pubmed: 36821617
doi: 10.34067/KID.0001582022
pii: 02200512-202302000-00019
pmc: PMC10103386
doi:

Substances chimiques

Antineoplastic Agents 0

Banques de données

ClinicalTrials.gov
['NCT03816332', 'NCT04339062']

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-271

Informations de copyright

Copyright © 2022 by the American Society of Nephrology.

Références

Kidney Int Rep. 2021 Dec 08;7(3):618-623
pubmed: 35257075
Hypertension. 2022 Nov;79(11):2611-2621
pubmed: 36093785
Diabetologia. 2016 Dec;59(12):2546-2551
pubmed: 27628105
Kidney Med. 2021 Oct 08;3(6):1074-1081
pubmed: 34939017
N Engl J Med. 2014 Dec 11;371(24):2277-2287
pubmed: 25394321
Clin Pharmacokinet. 2019 Jul;58(7):835-857
pubmed: 30815848
Blood Cancer J. 2020 Mar 3;10(3):28
pubmed: 32127527
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41
pubmed: 26728585
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1224-F1230
pubmed: 31545924
N Engl J Med. 2018 Dec 27;379(26):2517-2528
pubmed: 30501481
JAMA Oncol. 2020 Jan 01;6(1):116-124
pubmed: 31563959
JAMA Netw Open. 2019 Aug 2;2(8):e198890
pubmed: 31397860
Ann Intern Med. 2005 Dec 6;143(11):777-84
pubmed: 16330788
J Immunother Cancer. 2022 Sep;10(9):
pubmed: 36137651
Ann Oncol. 2019 Dec 1;30(Suppl_10):x21-x26
pubmed: 31626273
Kidney Int. 2021 Dec;100(6):1214-1226
pubmed: 34534550
Biol Blood Marrow Transplant. 2014 Jun;20(6):890-5
pubmed: 24650678
Eur Radiol. 2023 Mar;33(3):2227-2238
pubmed: 36255488
Kidney Int Rep. 2020 Oct 16;6(1):66-77
pubmed: 33426386
Nephrol Dial Transplant. 2021 Dec 2;36(12):2241-2247
pubmed: 33374011
J Am Soc Nephrol. 2021 May 3;32(5):1249-1261
pubmed: 33833079
Nat Rev Nephrol. 2015 Jun;11(6):354-70
pubmed: 25734768
Blood Cancer J. 2022 Aug 18;12(8):119
pubmed: 35982035
Clin Kidney J. 2022 Aug 31;16(5):817-826
pubmed: 37151409
Kidney Int. 2021 May;99(5):1249-1250
pubmed: 33892871
Ann Oncol. 2021 Apr;32(4):512-521
pubmed: 33453391
J Am Soc Nephrol. 2022 May;33(5):1033-1044
pubmed: 35321939
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34625513
J Am Soc Nephrol. 2021 May 3;32(5):1163-1173
pubmed: 33685975
Adv Chronic Kidney Dis. 2022 Mar;29(2):188-200.e1
pubmed: 35817526
N Engl J Med. 2017 Jan 12;376(2):191-192
pubmed: 28076715
Am J Kidney Dis. 2022 Sep;80(3):341-352
pubmed: 35217094
Int J Mol Sci. 2021 Mar 27;22(7):
pubmed: 33801659
Kidney Int. 2018 Jul;94(1):199-205
pubmed: 29759418
ACS Chem Biol. 2016 May 20;11(5):1245-54
pubmed: 26863403
J Immunother Cancer. 2023 Jan;11(1):
pubmed: 36657813
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Am J Med Sci. 2013 Jul;346(1):32-7
pubmed: 23103439
Blood Adv. 2019 Jun 25;3(12):1799-1807
pubmed: 31196847
Kidney Int. 2021 Oct;100(4):945-947
pubmed: 34556301
Blood. 2019 Nov 28;134(22):1919-1928
pubmed: 31582362
Am J Kidney Dis. 2020 Jul;76(1):63-71
pubmed: 31973908
Clin Cancer Res. 2018 Sep 1;24(17):4066-4071
pubmed: 29650751
Kidney Med. 2020 Apr 18;2(3):359-364
pubmed: 32734255
J Clin Oncol. 2017 Dec 10;35(35):3898-3905
pubmed: 28976790
Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):135-141
pubmed: 30584024
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16296-300
pubmed: 17060635
Kidney Int Rep. 2021 May 04;6(7):1992-1995
pubmed: 34307995
Am J Kidney Dis. 2022 Jan;79(1):120-124
pubmed: 34118303
Leukemia. 2020 Sep;34(9):2430-2440
pubmed: 32094461
Clin Kidney J. 2021 May 08;14(9):2012-2022
pubmed: 34476087
Clin J Am Soc Nephrol. 2022 Jun;17(6):922-933
pubmed: 35063968
J Oncol Pharm Pract. 2023 Sep;29(6):1326-1333
pubmed: 35946111
Nat Commun. 2016 Feb 24;7:10822
pubmed: 26905694
Nephrol Dial Transplant. 2023 May 4;38(5):1071-1079
pubmed: 35090037
Kidney Int. 2021 Jul;100(1):196-205
pubmed: 33359528
J Am Soc Nephrol. 2022 Jun;33(6):1154-1171
pubmed: 35523579
Adv Chronic Kidney Dis. 2022 Mar;29(2):103-115.e1
pubmed: 35817518
Am J Kidney Dis. 2022 Jun;79(6):904-908
pubmed: 34508832
Kidney Int Rep. 2021 Feb 02;6(4):1022-1031
pubmed: 33912752
Kidney360. 2020 Mar 18;1(5):399-402
pubmed: 35369378
Blood. 2012 May 10;119(19):4391-4
pubmed: 22331188
Ann Oncol. 2015 Nov;26(11):2305-10
pubmed: 26347114
PLoS One. 2019 Feb 20;14(2):e0211228
pubmed: 30785921
J Am Soc Nephrol. 2020 Feb;31(2):435-446
pubmed: 31896554
Clin Pharmacol Ther. 2019 May;105(5):1187-1195
pubmed: 30449032
Bone Marrow Transplant. 2022 Sep;57(9):1442-1444
pubmed: 35661834
Nephrol Dial Transplant. 2022 Aug 22;37(9):1616-1626
pubmed: 33295615
N Engl J Med. 2021 Sep 9;385(11):e34
pubmed: 34496190
J Clin Invest. 1998 Jul 1;102(1):107-14
pubmed: 9649563
Kidney Int. 2021 Apr;99(4):967-976
pubmed: 32828756
Eur J Clin Pharmacol. 2021 Feb;77(2):179-188
pubmed: 33319340
Clin J Am Soc Nephrol. 2012 Oct;7(10):1713-21
pubmed: 22879440
Kidney Int Rep. 2020 Mar 09;5(4):485-493
pubmed: 32274452
Kidney360. 2020 Nov 11;2(1):154-166
pubmed: 35368816
J Am Soc Hypertens. 2018 Jun;12(6):409-425
pubmed: 29703600
Clin Kidney J. 2018 Oct;11(5):670-680
pubmed: 30288263
Lancet Haematol. 2019 Apr;6(4):e217-e228
pubmed: 30872075
N Engl J Med. 2016 Jan 28;374(4):323-32
pubmed: 26641137
Breast Cancer Res Treat. 2016 Apr;156(2):343-9
pubmed: 27006189
Kidney Int Rep. 2022 Dec 05;8(3):628-641
pubmed: 36938084
Kidney Int. 2020 Sep;98(3):789-791
pubmed: 32828243
Kidney Int Rep. 2021 Sep 01;6(10):2733-2734
pubmed: 34622115
N Engl J Med. 2019 Nov 14;381(20):1977
pubmed: 31722162
Br J Cancer. 2018 Sep;119(6):663-669
pubmed: 30197417
Adv Chronic Kidney Dis. 2021 Sep;28(5):477-489.e1
pubmed: 35190114
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
JAMA Oncol. 2022 Feb 01;8(2):242-250
pubmed: 34913959
J Am Soc Nephrol. 2019 Feb;30(2):187-200
pubmed: 30642877
Clin J Am Soc Nephrol. 2006 Jul;1(4):685-94
pubmed: 17699273
J Am Soc Nephrol. 2019 May;30(5):824-839
pubmed: 30971456
N Engl J Med. 2021 Jul 1;385(1):46-58
pubmed: 34192431
Nephrol Dial Transplant. 2022 Nov 23;37(12):2569-2580
pubmed: 35687020
Kidney Med. 2022 Aug 12;4(10):100533
pubmed: 36185705
Clin J Am Soc Nephrol. 2022 Apr;17(4):527-534
pubmed: 35210280
Expert Opin Ther Targets. 2017 Dec;21(12):1095-1110
pubmed: 29076382
Mayo Clin Proc. 2022 Jul;97(7):1294-1304
pubmed: 35787856
Kidney Int. 2022 Oct;102(4):930-935
pubmed: 35964800
Nephrol Dial Transplant. 2022 Aug 22;37(9):1598-1608
pubmed: 33374000
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):121-123
pubmed: 35977777
Circ Res. 2021 Apr 2;128(7):1040-1061
pubmed: 33793337
Int J Gynecol Cancer. 2020 Jan;30(1):89-93
pubmed: 31792084
Med Res Rev. 2014 Jan;34(1):190-221
pubmed: 23720094
Kidney Int. 2020 Jan;97(1):163-174
pubmed: 31901340
Curr Oncol Rep. 2012 Aug;14(4):285-94
pubmed: 22544560
Lancet Oncol. 2022 Aug;23(8):1078-1086
pubmed: 35809595
Kidney Int. 2022 Dec;102(6):1320-1330
pubmed: 36007598
J Clin Oncol. 2020 Aug 10;38(23):2647-2657
pubmed: 32574117
JAMA. 2017 Dec 5;318(21):2099-2110
pubmed: 29209721
Endocrine. 2017 Apr;56(1):121-128
pubmed: 28155175
Biol Blood Marrow Transplant. 2019 Dec;25(12):2431-2437
pubmed: 31394272
Clin Genitourin Cancer. 2018 Jun;16(3):e645-e653
pubmed: 29339044
J Clin Oncol. 2017 Sep 1;35(25):2875-2884
pubmed: 28580882
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33849926

Auteurs

Marco Bonilla (M)

Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois.

Prakash Gudsoorkar (P)

Division of Nephrology & Kidney Clinical Advancement, Research & Education (C.A.R.E.) Program, University of Cincinnati, Cincinnati, Ohio.

Rimda Wanchoo (R)

Glomerular Center at Northwell Health, Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.

Sandra M Herrmann (SM)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Kenar D Jhaveri (KD)

Glomerular Center at Northwell Health, Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH